Nova imunoterapia pode abrir caminho para tratar asma por alergia
Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the immune system's response against leukemias and other cancers. In a study published in the Journal of Experimental Medicine (JEM), researchers in Switzerland